btw, this Dr is getting them late in the development of the disease. i think he is a lung dr. :
Marcus AureliusIn reply to Aggie95 • 6:30pAG
Yes. I would be more comfortable with more widespread re-opening knowing there was at least one effective drug. As far as mortality effects. Unfortunately has not been proven yet. But those studies are pending. Tocilizumab will prove to reduce mortality I am certain. Hopeful HCQ / ARB trials will prove some benefits.
Marcus Aurelius said:
Not understood completely. But 2 modes of transmission. Aerosolization of respiratory droplets and touching surfaces with viral particles then touching your face. I’ve read articles touting both methods as being superior in transmission. IMO sustained intimate contact over 20 minutes with an infected individual is highest risk. Getting infected from a keypad while paying for your groceries much less likely. If everyone wears masks transmission rates drop 90%.
Marcus AureliusIn reply to normaleagle05 • 4:43p, 4/30/20AG
I read about it earlier in the month. I can’t find the link now sorry. That is based off the NIH Japan study of asymptomatic transmission. The large reduction in transmission by using surgical or cloth masks is theorized in asymptomatic patients. Studies have been done in smaller groups of symptomatic patients with coronavirus and influenza and have shown a much lower although improved reduction in transmission. This is why the CDC changed their recommendation recently for all to wear surgical or cloth masks in public indoor places when feasible. One would hope/assume that symptomatic people are not out in public, even with masks on.
https://www.nature.com/articles/s41591-020-0843-2
No material on this site is intended to be a substitute for professional